Clinical

Dataset Information

0

Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer

ABSTRACT: STRATEGIC-1 is a study designed to determine the best sequence of therapy in patients with metastatic colorectal cancer.

DISEASE(S): Unresectable Wild-type Kras Metastatic Colorectal Cancer,Metastatic Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2149166 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.
| S-EPMC11379652 | biostudies-literature
Unknown Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
| S-EPMC4521211 | biostudies-literature
Unknown Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma.
| S-EPMC8713315 | biostudies-literature
Genomics Broccoli Sprouts Extracts Trial (BEST-COPD-BioLINCC)
| PRJNA1250615 | ENA
Genomics Broccoli Sprouts Extracts Trial (BEST-COPD-BioLINCC)
| PRJNA1250616 | ENA
Unknown Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma.
| S-EPMC11027363 | biostudies-literature
Genomics Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST CLI-BioLINCC)
| PRJNA1189188 | ENA
Genomics Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia (BEST CLI-BioLINCC)
| PRJNA1189189 | ENA
Unknown Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma.
| S-EPMC11412210 | biostudies-literature
Unknown FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
| S-EPMC8130420 | biostudies-literature